BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 27996941)

  • 1. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
    Ruiz B; Serrano P; Moreno C
    J Investig Allergol Clin Immunol; 2016; 26(6):355-361. PubMed ID: 27996941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of component based diagnostics in IgE-mediated hymenoptera sting reactions.
    Neis MM; Merk HF
    Cutan Ocul Toxicol; 2012 Jun; 31(2):117-23. PubMed ID: 21995714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Api m10 Specific IgE and IgG4 After One Year of Bee Venom Immunotherapy.
    Pereira Santos MC; Lourenco T; Pereira Barbosa M; Branco Ferreira M
    Eur Ann Allergy Clin Immunol; 2020 Jul; 52(4):175-181. PubMed ID: 31939631
    [No Abstract]   [Full Text] [Related]  

  • 4. Component resolution reveals additional major allergens in patients with honeybee venom allergy.
    Köhler J; Blank S; Müller S; Bantleon F; Frick M; Huss-Marp J; Lidholm J; Spillner E; Jakob T
    J Allergy Clin Immunol; 2014 May; 133(5):1383-9, 1389.e1-6. PubMed ID: 24440283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergy.
    Müller U; Schmid-Grendelmeier P; Hausmann O; Helbling A
    Allergy; 2012 Aug; 67(8):1069-73. PubMed ID: 22676144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved recombinant Api m 1- and Ves v 5-based IgE testing to dissect bee and yellow jacket allergy and their correlation with the severity of the sting reaction.
    Šelb J; Kogovšek R; Šilar M; Košnik M; Korošec P
    Clin Exp Allergy; 2016 Apr; 46(4):621-30. PubMed ID: 26366855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects.
    Arzt L; Bokanovic D; Schrautzer C; Laipold K; Möbs C; Pfützner W; Herzog SA; Vollmann J; Reider N; Bohle B; Aberer W; Sturm GJ
    Allergy; 2018 Jun; 73(6):1223-1231. PubMed ID: 29171032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5.
    Müller UR; Johansen N; Petersen AB; Fromberg-Nielsen J; Haeberli G
    Allergy; 2009 Apr; 64(4):543-8. PubMed ID: 19120073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. rApi m 3 and rApi m 10 improve detection of honey bee sensitization in Hymenoptera venom-allergic patients with double sensitization to honey bee and yellow jacket venom.
    Frick M; Müller S; Bantleon F; Huss-Marp J; Lidholm J; Spillner E; Jakob T
    Allergy; 2015 Dec; 70(12):1665-8. PubMed ID: 26259841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts.
    Blank S; Seismann H; Michel Y; McIntyre M; Cifuentes L; Braren I; Grunwald T; Darsow U; Ring J; Bredehorst R; Ollert M; Spillner E
    Allergy; 2011 Oct; 66(10):1322-9. PubMed ID: 21658068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy.
    Blank S; Etzold S; Darsow U; Schiener M; Eberlein B; Russkamp D; Wolf S; Graessel A; Biedermann T; Ollert M; Schmidt-Weber CB
    Hum Vaccin Immunother; 2017 Oct; 13(10):2482-2489. PubMed ID: 28494206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3).
    Grunwald T; Bockisch B; Spillner E; Ring J; Bredehorst R; Ollert MW
    J Allergy Clin Immunol; 2006 Apr; 117(4):848-54. PubMed ID: 16630944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of sIgE/T-IgE in Predicting Systemic Reactions: Retrospective Analysis of 54 Honeybee Venom Allergy Cases in North China.
    Guan K; Li LS; Yin J
    Chin Med J (Engl); 2016 Sep; 129(17):2091-5. PubMed ID: 27569237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Reactive Carbohydrate Determinant in
    Abram DM; Fernandes LGR; Perez-Riverol A; Regina Brochetto-Braga M; Zollner RL
    Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33050082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic precision of component-resolved vs. extract-based in vitro diagnosis of hymenoptera venom allergy: effects on clinical management.
    Seyfarth F; Miguel D; Schliemann S; Hipler UC
    J Dtsch Dermatol Ges; 2017 May; 15(5):507-515. PubMed ID: 28485877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune and clinical response to honeybee venom in beekeepers.
    Matysiak J; Matysiak J; Bręborowicz A; Kycler Z; Dereziński P; Kokot ZJ
    Ann Agric Environ Med; 2016; 23(1):120-4. PubMed ID: 27007529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3.
    Blank S; Seismann H; Bockisch B; Braren I; Cifuentes L; McIntyre M; Rühl D; Ring J; Bredehorst R; Ollert MW; Grunwald T; Spillner E
    J Immunol; 2010 May; 184(9):5403-13. PubMed ID: 20348419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The putative serine protease inhibitor Api m 6 from Apis mellifera venom: recombinant and structural evaluation.
    Michel Y; McIntyre M; Ginglinger H; Ollert M; Cifuentes L; Blank S; Spillner E
    J Investig Allergol Clin Immunol; 2012; 22(7):476-84. PubMed ID: 23397669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylaxis caused by the new ant, Pachycondyla chinensis: demonstration of specific IgE and IgE-binding components.
    Kim SS; Park HS; Kim HY; Lee SK; Nahm DH
    J Allergy Clin Immunol; 2001 Jun; 107(6):1095-9. PubMed ID: 11398091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy.
    Frick M; Fischer J; Helbling A; Ruëff F; Wieczorek D; Ollert M; Pfützner W; Müller S; Huss-Marp J; Dorn B; Biedermann T; Lidholm J; Ruecker G; Bantleon F; Miehe M; Spillner E; Jakob T
    J Allergy Clin Immunol; 2016 Dec; 138(6):1663-1671.e9. PubMed ID: 27372568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.